Advertisement

Topics

Danaher Corporation Strategy, SWOT and Corporate Finance Report Prices from USD $175

12:52 EST 1 Dec 2016 | BioPortfolio Reports

Summary
Danaher Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.



Key Findings
Detailed information on Danaher Corporation required for business and competitor intelligence needs
A study of the major internal and external factors affecting Danaher Corporation in the form of a SWOT analysis
An indepth view of the business model of Danaher Corporation including a breakdown and examination of key business segments
Intelligence on Danaher Corporation's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Danaher Corporation, such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends



ReasonsToBuy
Gain understanding of Danaher Corporation and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Danaher Corporation as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Danaher Corporation's business structure, strategy and prospects

Key Highlights
Danaher Corporation Danaher or 'the company' is engaged in the designing, manufacturing and marketing of professional, medical, industrial and commercial products and services. The company operates globally with major presence in the US, China, Germany and Japan. It is headquartered in Washington, DC, and employed about 71,000 people as of December 31, 2014.

Original Article: Danaher Corporation Strategy, SWOT and Corporate Finance Report Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Danaher Corporation Strategy, SWOT and Corporate Finance Report Prices from USD $175"

Quick Search
Advertisement
 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...